Total Payments
$6,486
2024 Payments
$1,298
Companies
38
Transactions
373
Medicare Patients
8,735
Medicare Billing
$608,459
Payment Breakdown by Category
Food & Beverage$6,486 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,486 | 373 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,332 | 105 | $0 (2024) |
| ABBVIE INC. | $814.62 | 41 | $0 (2024) |
| Amgen Inc. | $566.45 | 30 | $0 (2024) |
| Novo Nordisk Inc | $565.35 | 29 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $444.25 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $332.83 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $295.46 | 20 | $0 (2024) |
| Lilly USA, LLC | $234.02 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $233.15 | 15 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $214.43 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,298 | 67 | ABBVIE INC. ($291.94) |
| 2023 | $1,206 | 56 | ABBVIE INC. ($310.44) |
| 2022 | $586.99 | 31 | Novo Nordisk Inc ($167.92) |
| 2021 | $256.37 | 14 | Amgen Inc. ($108.45) |
| 2020 | $583.58 | 33 | PFIZER INC. ($174.17) |
| 2019 | $1,113 | 74 | PFIZER INC. ($447.05) |
| 2018 | $810.10 | 55 | PFIZER INC. ($276.65) |
| 2017 | $632.27 | 43 | PFIZER INC. ($114.78) |
All Payment Transactions
373 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: VACCINES | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: PAIN | ||||||
| 11/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes Care | ||||||
| 10/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: VACCINES | ||||||
| 10/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: Obesity | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Obesity | ||||||
| 09/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Bone Health | ||||||
| 09/20/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $2.64 | General |
| Category: PAIN | ||||||
| 09/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.62 | General |
| 09/18/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,824 | 3,033 | $483,499 | $135,783 |
| 2022 | 21 | 2,186 | 3,450 | $536,934 | $150,452 |
| 2021 | 20 | 2,078 | 3,428 | $527,982 | $151,316 |
| 2020 | 24 | 2,647 | 4,191 | $643,162 | $170,908 |
Total Patients
8,735
Total Services
14,102
Medicare Billing
$608,459
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 307 | 829 | $276,886 | $76,016 | 27.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 159 | 159 | $62,487 | $20,964 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 196 | 232 | $51,968 | $12,383 | 23.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 28 | 30 | $19,330 | $8,482 | 43.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 150 | 367 | $10,643 | $3,456 | 32.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 193 | 209 | $8,360 | $2,729 | 32.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 33 | 34 | $6,222 | $2,572 | 41.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 41 | 47 | $11,985 | $2,356 | 19.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 236 | 512 | $10,240 | $1,631 | 15.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 49 | $4,018 | $1,542 | 38.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 115 | 121 | $8,591 | $1,194 | 13.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 28 | 30 | $2,460 | $944.10 | 38.4% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 217 | 299 | $5,980 | $684.40 | 11.4% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 16 | 16 | $1,008 | $249.60 | 24.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 13 | 13 | $741.00 | $247.78 | 33.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 12 | 50 | $1,500 | $210.00 | 14.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 32 | 36 | $1,080 | $122.76 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 268 | 732 | $244,488 | $67,454 | 27.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 211 | 211 | $82,923 | $28,588 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 260 | 322 | $72,128 | $19,257 | 26.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 91 | 127 | $32,385 | $7,779 | 24.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 22 | 22 | $12,650 | $3,827 | 30.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 251 | 287 | $11,480 | $3,779 | 32.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 157 | 372 | $10,788 | $3,566 | 33.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $6,258 | $2,425 | 38.8% |
About Dr. David Mudd, MD
Dr. David Mudd, MD is a Internal Medicine healthcare provider based in Brockton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750376794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Mudd, MD has received a total of $6,486 in payments from pharmaceutical and medical device companies, with $1,298 received in 2024. These payments were reported across 373 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,486).
As a Medicare-enrolled provider, Mudd has provided services to 8,735 Medicare beneficiaries, totaling 14,102 services with total Medicare billing of $608,459. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Brockton, MA
- Active Since 09/15/2005
- Last Updated 05/02/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1750376794
Products in Payments
- CHANTIX (Drug) $785.27
- UBRELVY (Drug) $432.52
- ELIQUIS (Drug) $409.70
- EVENITY (Biological) $265.58
- VRAYLAR (Drug) $225.69
- ENTRESTO (Drug) $219.59
- Enbrel (Biological) $193.53
- PREVNAR 20 (Biological) $183.00
- FARXIGA (Drug) $174.65
- XARELTO (Drug) $155.43
- JANUVIA (Drug) $153.13
- Ozempic (Drug) $132.97
- LYRICA (Drug) $132.23
- ACCRUFER (Drug) $117.38
- TRELEGY ELLIPTA (Drug) $107.68
- Prolia (Biological) $107.34
- Wegovy (Drug) $103.64
- TOUJEO (Drug) $91.73
- ORENCIA (Biological) $89.05
- Rybelsus (Drug) $84.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brockton
Bahige Asaker, Do, DO
Internal Medicine — Payments: $17,629
Internal Medicine $17,629
Joseph Kagan, Md, MD
Internal Medicine — Payments: $17,322
Internal Medicine $17,322
Andrew Kriegel, Md, MD
Internal Medicine — Payments: $12,403
Internal Medicine $12,403
Dino Constantinou, Md, MD
Internal Medicine — Payments: $6,970
Internal Medicine $6,970
Elisa Mulcahy, Md, MD
Internal Medicine — Payments: $6,670
Internal Medicine $6,670
Robert Covett, D.o, D.O
Internal Medicine — Payments: $6,333
Internal Medicine $6,333